Tickerplace logo

Tickerplace

CytoMed Therapeutics Limited logo

GDTCCytoMed Therapeutics Limited

GDTC Stock Price, Valuation & Chart | CytoMed Therapeutics Limited

Compare
$0.900-0.01 (-0.97%)

At close · 02 Sept 2026, 07:59 pm

Sector: HealthcareIndustry: BiotechnologyGDTC intrinsic valueGDTC calculated fair value vs price
OverviewFinancialsDividendsRatios

GDTC Historical price chart

GDTC Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization10.65M
PE Ratio-4.17
EPS-0.22
Trading Volume12.93K
Today's High/Low0.9/0.85
Dividend Yield0.00
52 Week High/Low3.68/0.68
Shares Outstanding11.83M
GDTC Financial Statement
GDTC Analyst ratings
GDTC Analysis & performance metrics

GDTC Company profile

CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The…

GDTC Management team

Management
Jieming Zeng M.D., Ph.D.CTO
Chief Scientific & Medical Officer and Director
Yvonne GohCFO
Chief Financial Officer
Chee Kong Choo
Executive Chairman
Yoong Ying Tan
Chief Corporate Officer
Tien Wee Luk M.D.
Chief Clinical Officer
Total 5 executives

GDTC Frequently asked questions

What is CytoMed Therapeutics Limited (GDTC) Stock Price?

Current stock price of CytoMed Therapeutics Limited (GDTC) stock is $0.900. The stock price is -0.97% lower in the session. The intraday range can be seen from this page. Volume of CytoMed Therapeutics Limited (GDTC) stock is 12.93K.

Last updated at 02 Sept 2026, 07:59 pm.

Why is the CytoMed Therapeutics Limited (GDTC) stock price going up or down today?

The stock price of CytoMed Therapeutics Limited (GDTC) can change with earnings, company news, and overall market sentiment. CytoMed Therapeutics Limited operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the CytoMed Therapeutics Limited stock expensive at its current price?

Whether CytoMed Therapeutics Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for GDTC on this page is -4.17. EPS on this page is -0.22. Compare those figures with peers and growth expectations before deciding if the current CytoMed Therapeutics Limited price is justified.

How has the stock price of CytoMed Therapeutics Limited (GDTC) performed historically?

Historical performance for CytoMed Therapeutics Limited (GDTC) is shown on the price chart on this page. Review multi-period moves alongside volume to see how GDTC reacted to past earnings and market events.

Should I buy CytoMed Therapeutics Limited (GDTC) stock, at this price?

Buying CytoMed Therapeutics Limited (GDTC) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.